Awiqli Flextouch (insulin icodec)
New biologic
- Region
- 🇺🇸 US
- Active substance
- insulin icodec
- Company
- Novo Nordisk Inc
- Status
- Approved
- FDA approval
- Thu 26 Mar 2026
- Designations
- New biologic
- Application
- BLA761326
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Thu 26 Mar 2026🇺🇸 FDA approval
FDA approves Awiqli Flextouch (insulin icodec), a new medicine
Novo Nordisk Inc; BLA761326; New biologic; injection · source
Same substance in other markets
Follow Awiqli Flextouch
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.